The deadline to enter the 2011 GE and Science Prize for Young Life Scientists is 1st August 2011. Established in 1995, the prize recognizes outstanding young scientists from around the world who have completed their PhDs in the area of molecular biology* during 2010.
GE Healthcare Life Sciences and the journal Science, co-sponsors of the prize, believe that support for young scientists at the start of their careers is critical to the future of continued life sciences research. Past winners have made an impact in life sciences research and have used the prize as a stepping-stone in their scientific research careers.
To be eligible for the prize, entrants must submit a 1,000-word essay which describes their doctoral thesis. The grand prize winner will have his or her essay published in Science and receive a prize of US$25,000. Prizes are also awarded each year to finalists in four geographic regions, each winner receiving US$5,000. All winners will be invited to an award ceremony in December 2011 in Stockholm, Sweden to receive their prize and to meet with the current Nobel laureates. Full details on how to enter and information on past winners can be found at www.gescienceprize.org.
Commenting on this year's prize, Kieran Murphy, President and CEO of GE Healthcare Life Sciences said "The GE and Science Prize for Young Life Scientists was set up over fifteen years ago to recognize the talent of the world's most promising young researchers as they embark on their careers. By encouraging scientific progress in our understanding of genes and proteins, the prize is contributing to the global research effort to tackle some of healthcare's most pressing challenges."
"Supporting young scientists as they embark on their careers is vital to the future of molecular biology," said Monica Bradford, Executive Editor of Science. "We are proud to be part of the prize which acknowledges the important studies these promising scientists conduct and encourages them to make further strides to advance global scientific understanding."
Related news articles:
- GE Healthcare's Profile
* For the purpose of this prize, molecular biology is defined as "that part of biology which attempts to interpret biological events in terms of the physico-chemical properties of molecules in a cell." (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th Edition)
About GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.
Our "healthymagination" vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries.
AAAS - Advancing science, serving society
The journal Science, published by the American Association for the Advancement of Science (AAAS), was founded in 1880 by Thomas Edison and ranks as the world's leading scientific journal. Each week, Science provides over 129,000 subscribers around the world with peer-reviewed original research and more. The AAAS mission seeks to advance science and innovation throughout the world for the benefit of all people. Four primary program areas fulfil the AAAS mission: Science and Policy, International Programs, Education and Human Resources, and Project 2061.